宏源药业
(301246)
| 流通市值：24.28亿 | | | 总市值：65.20亿 |
| 流通股本：1.49亿 | | | 总股本：4.00亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 426,063,885 | 2,054,881,990.91 | 1,558,714,943.06 | 997,633,605.73 |
| 营业收入 | 426,063,885 | 2,054,881,990.91 | 1,558,714,943.06 | 997,633,605.73 |
| 二、营业总成本 | 393,251,587.27 | 1,965,280,503.57 | 1,455,076,558.31 | 928,911,489.22 |
| 营业成本 | 359,024,437.28 | 1,788,014,080.66 | 1,331,410,175.72 | 852,823,576.03 |
| 税金及附加 | 2,347,202.48 | 13,347,161.83 | 7,884,619.72 | 4,874,889.45 |
| 销售费用 | 8,475,283.66 | 37,690,489.34 | 27,696,692.94 | 17,863,131.92 |
| 管理费用 | 9,886,104.43 | 60,806,330.36 | 40,959,272.15 | 28,163,902.61 |
| 研发费用 | 15,176,270.87 | 68,816,103.15 | 49,373,159.61 | 26,571,327.7 |
| 财务费用 | -1,657,711.45 | -3,393,661.77 | -2,247,361.83 | -1,385,338.49 |
| 其中:利息费用 | 2,557,508 | 13,397,012.49 | 9,198,349.47 | 5,296,841.83 |
| 其中:利息收入 | 2,584,762.4 | 17,051,206.89 | 10,561,920.88 | 5,637,069.67 |
| 加:公允价值变动收益 | 3,996,997.27 | 2,860,235.62 | 18,003,316.23 | 11,155,991.87 |
| 加:投资收益 | -849,561.02 | 19,419,742.61 | -7,781,276.23 | -6,485,605.07 |
| 资产处置收益 | 75,199.82 | 568,537.69 | 428,693.01 | 357,778.33 |
| 资产减值损失(新) | -4,715,838.5 | -26,379,959.24 | -10,406,058.98 | -10,406,058.98 |
| 信用减值损失(新) | -135,590.14 | -4,511,454.35 | -5,336,462.68 | -4,897,120.18 |
| 其他收益 | 3,982,300.65 | 24,085,914.93 | 23,550,275.05 | 19,149,566.16 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 35,165,805.81 | 105,644,504.6 | 122,096,871.15 | 77,596,668.64 |
| 加:营业外收入 | 54,045.78 | 156,173.91 | 125,073.91 | 38,701.72 |
| 减:营业外支出 | 141,200.01 | 7,242,614.95 | 7,237,692.41 | 1,542,457.03 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 35,078,651.58 | 98,558,063.56 | 114,984,252.65 | 76,092,913.33 |
| 减:所得税费用 | 3,879,589.96 | 11,389,437.32 | 18,684,073.43 | 11,069,473.45 |
| 六、净利润 | 31,199,061.62 | 87,168,626.24 | 96,300,179.22 | 65,023,439.88 |
| 持续经营净利润 | 31,199,061.62 | 87,168,626.24 | 96,300,179.22 | 65,023,439.88 |
| 归属于母公司股东的净利润 | 31,199,061.62 | 87,168,626.24 | 96,300,179.22 | 65,023,439.88 |
| (一)基本每股收益 | 0.08 | 0.22 | 0.25 | 0.17 |
| (二)稀释每股收益 | 0.08 | 0.22 | 0.25 | 0.17 |
| 九、综合收益总额 | 31,199,061.62 | 87,168,626.24 | 96,300,179.22 | 65,023,439.88 |
| 归属于母公司股东的综合收益总额 | 31,199,061.62 | 87,168,626.24 | 96,300,179.22 | 65,023,439.88 |
| 公告日期 | 2024-04-23 | 2024-04-23 | 2023-10-28 | 2023-08-31 |
| 审计意见(境内) | | 标准无保留意见 | | |